Paradigm Biocapital Advisors LP - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 141 filers reported holding KURA ONCOLOGY INC in Q4 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.4%.

Quarter-by-quarter ownership
Paradigm Biocapital Advisors LP ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q2 2024$93,465,855
+39.8%
4,539,381
+44.8%
3.58%
+52.0%
Q1 2024$66,877,805
+268.3%
3,135,387
+148.3%
2.35%
+176.9%
Q4 2023$18,159,467
+64.2%
1,262,828
+4.1%
0.85%
+13.2%
Q3 2023$11,060,991
+4.0%
1,212,828
+20.7%
0.75%
-8.6%
Q2 2023$10,631,9271,004,9080.82%
Other shareholders
KURA ONCOLOGY INC shareholders Q4 2023
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,849,947$25,899,0005.33%
Asymmetry Capital Management, L.P. 502,275$7,032,0003.73%
Affinity Asset Advisors, LLC 560,000$7,840,0002.85%
Deep Track Capital, LP 2,550,000$35,700,0002.52%
ACUTA CAPITAL PARTNERS, LLC 291,884$4,086,0001.72%
EcoR1 Capital, LLC 3,724,437$52,142,0001.66%
SPHERA FUNDS MANAGEMENT LTD. 832,238$11,651,0001.28%
Ghost Tree Capital, LLC 225,000$3,150,0001.13%
BVF INC/IL 2,064,212$28,899,0001.05%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,513,756$49,193,0001.03%
View complete list of KURA ONCOLOGY INC shareholders